Scarica l'app Stockscreener
1.2701
4.10%
0.0501
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PACB Giù?
Forum
Previsione
Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie
PacBio (PACB) Launches New Sequencing Technology for Global Dist - GuruFocus
PacBio ships new sequencing chemistry, cuts genome cost - Investing.com
AI-tuned PacBio upgrade brings sub-$300 human genomes at scale - Stock Titan
Pacific Biosciences: Pressure Is Rising (NASDAQ:PACB) - Seeking Alpha
PACB (Pacific Biosciences of California) ROC % : -47.66% (As of Mar. 2026) - GuruFocus
Q4 2025 Pacific Biosciences of California Inc Earnings Call Transcript - GuruFocus
PACB Stock Price, Quote & Chart | PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) - ChartMill
PacBio to Participate in the Jefferies Global Healthcare Conference - Yahoo Finance
Here's why you should add PacBio stock to your portfolio now - MSN
Pacific Biosciences of California (PACB) Stock Price, News & Analysis - MarketBeat
Pacific Biosciences of California sets $300 price point for 20x human genome sequencing on Revio - Traders Union
PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology - Yahoo Finance
PACB Secures $7.2M in Seed Funding and Partners with Blank Bio - GuruFocus
PacBio wins Basecamp Research deal for Trillion Gene Atlas initiative - MSN
Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology - BioSpace
AI lab Blank Bio raises $7.2M, teams with PacBio on tumor RNA - Stock Titan
PacBio tumbles after narrowing full-year revenue guidance - MSN
Sequencing constraints lifted as Pacific Biosciences of California enables combined genetic and methylation detection - Traders Union
PacBio expects $165M-$175M 2026 revenue as SPRQ-Nx ships later this month - MSN
Pacific Biosciences of California introduces HiFi Starter Kit to expand long-read sequencing access - Traders Union
Pacific Biosciences stock (US6932471010): Latest developments and market position - AD HOC NEWS
PACB SEC FilingsPacific Biosc 10-K, 10-Q, 8-K Forms - Stock Titan
PACB Technical Analysis | Trend, Signals & Chart Patterns | PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) - ChartMill
PacBio (PACB) Q1 earnings report preview: What to look for - MSN
Pacific Biosciences (PACB) Reports Q1 EPS - Insider Monkey
Pacific Biosciences of California brings global researchers together in Fukuoka - Traders Union
Why PacBio (PACB) Shares Are Getting Obliterated Today - Yahoo Finance
5 Best Penny Stocks to Buy Before They Explode - Insider Monkey
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness - Yahoo Finance
Pacific Biosciences of California launches PacBioPRISM tour finale in Japan to drive HiFi innovation - Traders Union
Pacific Biosciences of California, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PACB) 2026-05-11 - Seeking Alpha
PACB Maintained by Barclays -- Price Target Raised to $1.50 - GuruFocus
TradingKey - TradingKey
Long-read genome scan spots key variants in unexplained subfertility - Stock Titan
PacBio (PACB) Q1 2026 Earnings Call Transcript - AOL.com
Pacific Biosciences Of California (PACB) Q4 Loss Highlights Ongoing Break From Bullish Profitability Narratives - Sahm
Pacific Biosciences of California, Inc. Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
[10-Q] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Earnings Report - Stock Titan
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1Q 2026: Revenue $37.18M, EPS ($0.03) — 10-Q Summary - TradingView
Pacific Biosciences stock (US6932471010): Flat Q1 revenue amid funding pressure in U.S. research sec - AD HOC NEWS
Pacific Biosciences (PACB) Shares Drop Following Q1 Revenue Miss - GuruFocus
Pacific Biosciences Shares Fall Amid 1Q Revenue Pressures - Moomoo
Pacific Biosciences of California, Inc. (PACB) Stock Rises on Q1 2026 Earnings - Moomoo
PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down - TradingView
0.32%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):